Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.673% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COc1ccc(COC(=O)C2=C(C)NC(=O)NC2c2ccc(F)cc2)cc1
b CCC(COC(=O)Nc1ccc(Cl)cc1)N1C(=O)CSC1c1ccc(C)cc1
c COC(=O)c1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
Answer: a. COc1ccc(COC(=O)C2=C(C)NC(=O)NC2c2ccc(F)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(COC(=O)C2=C(C)NC(=O)NC2c2ccc(F)cc2)cc1
COc1ccc(COC(=O)C2=C(C)NC(=O)NC2c2ccc(F)cc2)cc1
(4-methoxyphenyl)methyl 4-(4-fluorophenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate